Crossmark Global Holdings’s Acorda Therapeutics, Inc. ACOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-67
Closed -$229K 1609
2018
Q2
$229K Buy
+67
New +$229K 0.01% 1475
2018
Q1
Sell
-82
Closed -$210K 1639
2017
Q4
$210K Hold
82
0.01% 1560
2017
Q3
$233K Buy
+82
New +$233K 0.01% 1481
2016
Q3
$233K Buy
+82
New +$233K 0.01% 1481